Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nerindocianine for Ureter Visualization in Pelvic Surgery
NCT03106038Phase 2Completed
- Sponsor
- LI-COR Biosciences
- Start
- Apr 2017
- Primary completion
- Nov 2018
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of nerindocianine in ureteral injury, sponsored by LI-COR Biosciences. Started Apr 2017; status: completed.
02
Drugs
nerindocianine
03
Conditions
ureteral injury
Beyond the preview
Go deeper on NCT03106038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03106038.